Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Talin (KIAA1027, TLN, TLN1, ILWEQ) | Login | Talin (KIAA1027, TLN, TLN1, ILWEQ) | ||||||||||||||||
|
||||||||||||||||||
| Tenascin (Cytotactin, Tenascin C, Glioma associated Extracellular Matrix Antigen, GMEM, Hexabrachion) | Login | Tenascin (Cytotactin, Tenascin C, Glioma associated Extracellular Matrix Antigen, GMEM, Hexabrachion) | ||||||||||||||||
|
||||||||||||||||||
| TrkB (Tyrosine Kinase Receptor B) | Login | TrkB (Tyrosine Kinase Receptor B) | ||||||||||||||||
|
||||||||||||||||||
| Hypoxia Inducible Factor 1b (HIF-1b, ARNT, Aryl hydrocarbon Receptor Nuclear Translocator) | Login | Hypoxia Inducible Factor 1b (HIF-1b, ARNT, Aryl hydrocarbon Receptor Nuclear Translocator) | ||||||||||||||||
|
||||||||||||||||||
| BRAF35 (B-raf35, c-Rmil, Serine/Threonine protein Kinase) | Login | BRAF35 (B-raf35, c-Rmil, Serine/Threonine protein Kinase) | ||||||||||||||||
|
||||||||||||||||||
| Somatostatin Receptor Type 1 (SSTr1) | Login | Somatostatin Receptor Type 1 (SSTr1) | ||||||||||||||||
|
||||||||||||||||||
| Glial Fibrillary Acidic Protein (GFAP) | Login | Glial Fibrillary Acidic Protein (GFAP) | ||||||||||||||||
|
||||||||||||||||||
| Neurofibromin, aa27-41 (NF1, WSS, NFNS, VRNF, NF, Neurofibromin 1, neurofibromatosis, type I, von Recklinghausen disease neurofibromin, Neurofibromatosis-Noonan syndrome, WATS, Watson Syndrome) | Login | Neurofibromin, aa27-41 (NF1, WSS, NFNS, VRNF, NF, Neurofibromin 1, neurofibromatosis, type I, von Recklinghausen disease neurofibromin, Neurofibromatosis-Noonan syndrome, WATS, Watson Syndrome) | ||||||||||||||||
|
||||||||||||||||||
| Somatostatin Receptor Type 2 (SSTr2) | Login | Somatostatin Receptor Type 2 (SSTr2) | ||||||||||||||||
|
||||||||||||||||||
| SynCAM | Login | SynCAM | ||||||||||||||||
|
||||||||||||||||||
| Cyclin E1 | Login | Cyclin E1 | ||||||||||||||||
|
||||||||||||||||||
| Cyclin E2 | Login | Cyclin E2 | ||||||||||||||||
|
||||||||||||||||||
| Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) | Login | Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) | ||||||||||||||||
|
||||||||||||||||||
| Cadherin N (Cadherin 2, Neuronal, CDH2) | Login | Cadherin N (Cadherin 2, Neuronal, CDH2) | ||||||||||||||||
|
||||||||||||||||||
| NFkB, p65, NT (NF-kB, Nuclear Factor kappa B, RelA) | Login | NFkB, p65, NT (NF-kB, Nuclear Factor kappa B, RelA) | ||||||||||||||||
|
||||||||||||||||||
| c-erbB2 (HER-2, neu Receptor) (BSA & Azide Free) | Login | c-erbB2 (HER-2, neu Receptor) (BSA & Azide Free) | ||||||||||||||||
|
||||||||||||||||||
| c-erbB2 (HER-2, neu Receptor) | Login | c-erbB2 (HER-2, neu Receptor) | ||||||||||||||||
|
||||||||||||||||||
| c-erbB2 (HER-2, neu Receptor) (BSA & Azide Free) | Login | c-erbB2 (HER-2, neu Receptor) (BSA & Azide Free) | ||||||||||||||||
|
||||||||||||||||||
| c-erbB2, mixed clones (HER-2, neu Receptor) | Login | c-erbB2, mixed clones (HER-2, neu Receptor) | ||||||||||||||||
|
||||||||||||||||||
| Cadherin E (Cadherin 1, E-Cadherin, L-CAM, Epithelial Cell Adhesion Molecule, Uvomorulin, CDH1) (BSA & Azide Free) | Login | Cadherin E (Cadherin 1, E-Cadherin, L-CAM, Epithelial Cell Adhesion Molecule, Uvomorulin, CDH1) (BSA & Azide Free) | ||||||||||||||||
|
||||||||||||||||||
| Caspase 8 (FLICE, MASH, Mch5) | Login | Caspase 8 (FLICE, MASH, Mch5) | ||||||||||||||||
|
||||||||||||||||||
| Caspase 8 (FLICE) (BSA & Azide Free) | Login | Caspase 8 (FLICE) (BSA & Azide Free) | ||||||||||||||||
|
||||||||||||||||||
| CD56 (NCAM-1, Neural Cell Adhesion Molecule) (BSA & Azide Free) | Login | CD56 (NCAM-1, Neural Cell Adhesion Molecule) (BSA & Azide Free) | ||||||||||||||||
|
||||||||||||||||||
| CD99 (MIC2, p30/32MIC2, Ewing’s Sarcoma Marker, E2 Antigen) (BSA & Azide Free) | Login | CD99 (MIC2, p30/32MIC2, Ewing’s Sarcoma Marker, E2 Antigen) (BSA & Azide Free) | ||||||||||||||||
|
||||||||||||||||||
| Epidermal Growth Factor Receptor (erbB, EGFR) | Login | Epidermal Growth Factor Receptor (erbB, EGFR) | ||||||||||||||||
|
||||||||||||||||||


